Notice of Availability of a Novel Dendrimer Based Detection Technology for Exclusive, Partially Exclusive or Non-exclusive Licenses, 61091 [E8-24512]

Download as PDF Federal Register / Vol. 73, No. 200 / Wednesday, October 15, 2008 / Notices Investigatory material compiled solely for the purpose of determining suitability, eligibility, or qualifications for federal civilian employment, military service, federal contracts, or access to classified information may be exempt pursuant to 5 U.S.C. 552a(k)(5), but only to the extent that such material would reveal the identity of a confidential source. An exemption rule for this record system has been promulgated in accordance with the requirements of 5 U.S.C. 553(b)(1), (2), and (3), (c) and (e) and published in 32 CFR part 312. For additional information contact the system manager. [FR Doc. E8–24436 Filed 10–14–08; 8:45 am] BILLING CODE 5001–06–P hereby gives notice of its intent to grant to ANP Technologies, Inc., 824 Interchange Boulevard, Newark, DE 19711, an exclusive license relative to United States Patent #6,716,450 entitled ‘‘Enhancing Protein Activity Through Nanoencapsulation’’, Yin, et al., issued April 6, 2004. Anyone wishing to object to the granting of this license has 15 days from the date of this notice to file written objections along with supporting evidence, if any. FOR FURTHER INFORMATION CONTACT: Michael D. Rausa, U.S. Army Research Laboratory, Office of Research and Technology Applications, ATTN: AMSRD–ARL–DP–P/Bldg. 434, Aberdeen Proving Ground, MD 21005– 5425, Telephone: (410) 278–5028. SUPPLEMENTARY INFORMATION: None. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E8–24510 Filed 10–14–08; 8:45 am] DEPARTMENT OF DEFENSE Department of the Army Department of the Army, DOD. Notice of availability. SUMMARY: The Department of the Army announces the general availability of exclusive, partially exclusive or nonexclusive licenses relative to a novel dendrimer technology as described in United States Patent #6,716,450 entitled ‘‘Enhancing Protein Activity Through Nanoencapsulation’’, Yin, et al., issued April 6, 2004. Licenses shall comply with 35 U.S.C. 209 and 37 CFR 404. FOR FURTHER INFORMATION CONTACT: Michael D. Rausa, U.S. Army Research Laboratory, Office of Research and Technology Applications, ATTN: AMSRD–ARL–DP–P/Bldg. 434, Aberdeen Proving Ground, MD 21005– 5425, Telephone: (410) 278–5028. SUPPLEMENTARY INFORMATION: None. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E8–24512 Filed 10–14–08; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army jlentini on PROD1PC65 with NOTICES Notice of Intent To Grant an Exclusive License to ANP Technologies, Inc. Department of the Army, DOD. Notice. AGENCY: ACTION: SUMMARY: In compliance with 37 CFR 404 et seq., the Department of the Army VerDate Aug<31>2005 18:32 Oct 14, 2008 Jkt 217001 Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E8–24497 Filed 10–14–08; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Method and Kit for Detecting Adenovirus Serotype 14 Virus ACTION: Department of the Army, DoD. Notice. DEPARTMENT OF DEFENSE Department of the Army AGENCY: ACTION: determine and/or monitor a subject’s hydration level for diagnostic, treatment, and prophylactic purposes. By determining/monitoring the hydration status of a subject, preventive measures may be applied to prevent heat injuries and deaths. AGENCY: BILLING CODE 3710–08–P Notice of Availability of a Novel Dendrimer Based Detection Technology for Exclusive, Partially Exclusive or Non-exclusive Licenses 61091 Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Intraoral Measurement of Saliva Osmolarity to Measure Hydration Status Department of the Army, DoD. Notice. AGENCY: ACTION: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ 096,941 entitled ‘‘Intraoral Measurement of Saliva Osmolarity to Measure Hydration Status,’’ filed September 15, 2008. The United States Government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention comprises a rapid, noninvasive method that uses saliva to SUMMARY: PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ 058,598 entitled ‘‘Method and Kit for Detecting Adenovirus Serotype 14 Virus,’’ filed June 4, 2008. The United States Government, as represented by the Secretary of the Army, has rights in this invention. Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: Adenovirus type 14 (Ad14) is an emerging pathogen that can cause life threatening diseases and large outbreaks. To improve the capability of the laboratory for diagnosing AD14 infection and to prepare for possible outbreak, a real-time PCR assay targeting a unique sequence in the hexon region of the adenovirus genome is disclosed. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E8–24488 Filed 10–14–08; 8:45 am] BILLING CODE 3710–08–P E:\FR\FM\15OCN1.SGM 15OCN1

Agencies

[Federal Register Volume 73, Number 200 (Wednesday, October 15, 2008)]
[Notices]
[Page 61091]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-24512]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability of a Novel Dendrimer Based Detection 
Technology for Exclusive, Partially Exclusive or Non-exclusive Licenses

AGENCY: Department of the Army, DOD.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Department of the Army announces the general availability 
of exclusive, partially exclusive or non-exclusive licenses relative to 
a novel dendrimer technology as described in United States Patent 
6,716,450 entitled ``Enhancing Protein Activity Through 
Nanoencapsulation'', Yin, et al., issued April 6, 2004. Licenses shall 
comply with 35 U.S.C. 209 and 37 CFR 404.

FOR FURTHER INFORMATION CONTACT: Michael D. Rausa, U.S. Army Research 
Laboratory, Office of Research and Technology Applications, ATTN: 
AMSRD-ARL-DP-P/Bldg. 434, Aberdeen Proving Ground, MD 21005-5425, 
Telephone: (410) 278-5028.

SUPPLEMENTARY INFORMATION: None.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E8-24512 Filed 10-14-08; 8:45 am]
BILLING CODE 3710-08-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.